目的 分析廈門大學(xué)附屬中山醫(yī)院使用阿伐曲泊帕片患者的病例特點(diǎn)和用藥情況。方法 回顧性分析2021年7月—2022年12月廈門大學(xué)附屬中山醫(yī)院使用阿伐曲泊帕片患者的病例資料，記錄患者基本信息、疾病、用藥情況，對阿伐曲泊帕片的用藥情況進(jìn)行匯總和合理性評價。結(jié)果 共抽取134份阿伐曲泊帕片用藥病例，用藥排名前3位的科室是血液科、肝膽外科、重癥醫(yī)學(xué)科。134份病例中合理120份，不合理14份，不合理類型主要包括適應(yīng)證不合理、用法用量不合理、用藥療程不合理。結(jié)論 阿伐曲泊帕片在廈門大學(xué)附屬中山醫(yī)院臨床應(yīng)用還有待進(jìn)一步的規(guī)范和探討。

Objective To analyze the case characteristics and medication situation of patients using Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University. Methods The case data of patients using Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University from July 2021 to December 2022 were retrospectively analyzed, the basic information, disease and drug use of patients were recorded, and the drug use of Avatrombopag Tablets was summarized and rational evaluation was made. Results A total of 134 cases of Avatrombopag Tablets were selected, and the top three departments were hematology, hepatobiliary surgery, and intensive care medicine. Among the 134 cases, 120 cases were reasonable, while 14 cases were unreasonable, including unreasonable indications, inappropriate usage and dosage, and inappropriate medication course. Conclusion The clinical application of Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University still needs to be further standardized and discussed.

R973